Ziprasidone for Improving Insulin Sensitivity in People With Schizophrenia Who Are at Risk for Diabetes

Clinical trial NCT00338949 · COMPLETED

Trial details

NCT number: NCT00338949
Sponsor: Veterans Medical Research Foundation
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Schizophrenia Metabolic Syndrome X Insulin Resistance

Start date: 2006-06-01
Primary completion: 2009-12-01
Enrollment: 77

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.